Product Name

Propranolol Hydrochloride

CAS Number

318-98-9

LGM Pharma is an API distributor. LGM Pharma can supply CGMP and/or DMF products, subject to availability and manufacturer requirements. LGM Pharma does not sell or supply APIs or finished dosage products to individual patients, doctors, pharmacies, or any pharmaceutical companies.

Questions? Call our customer API support number 1-(800)-881-8210

Product Name:
Propranolol Hydrochloride
CAS Number:
318-98-9
Indication:
For the prophylaxis of migraine.
Mode of Action:

Propranolol competes with sympathomimetic neurotransmitters such as catecholamines for binding at beta(1)-adrenergic receptors in the heart, inhibiting sympathetic stimulation. This results in a reduction in resting heart rate, cardiac output, systolic and diastolic blood pressure, and reflex orthostatic hypotension.

Pharmacodynamics:

Propranolol, the prototype of the beta-adrenergic receptor antagonists, is a competitive, nonselective beta-blocker similar to nadolol without intrinsic sympathomimetic activity. Propanolol is a racemic compound; the l-isomer is responsible for adrenergic blocking activity.

Metabolism:

Hepatic

Toxicity:

Symptoms of overdose include bradycardia, cardiac failure, hypotension, and brochospasm. LD50=565 mg/kg (orally in mice).

IUPAC:
(RS)-1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
ATC:
C07AA05
PubChem:
4946
DrugBank:
DB00571
Formula:
C16H21N1O2
Molecular Mass:
259.34
Synonyms:
(+-)-1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride, 1-(1-Naphthyloxy)-2-hydroxy-3-isopropylaminopropane hydrochloride, 1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol hydrochloride, 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride, 1-(Isopropylamino)-3-(alpha-naphthoxy)-2-propanol hydrochloride, 1-Isopropylamino-3-(1-naphthoxy)-propan-2-ol-hydrochloride, 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, hydrochloride, 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, hydrochloride, (+-)-, Acifol, Anaprilin, Anapriline, Angilol, Apsolol, Arcablock, Artensol, Avlocardyl, AY 64043, Beprane, Berkolol, beta Neg, beta-NEG, Beta-Tablinen, Beta-Timelets, Biocard, Blocaryl, Cardinol, Caridolol, CCRIS 1105, Cinlol, Ciplar, Corbeta, d,l-Propranolol hydrochloride, Deralin, Detensol, Dibudinate, DL-Anapriline, DL-Propranolol hydrochloride, Dociton, Dumopranol, Duranol, Duraprox, Efectolol, EINECS 206-268-7, EINECS 222-501-5, Elbrol, Emforal, Farprolol, Frekven, Half-Inderal, HemangeolHemangeol, Hemipralon, Herzbase, Herzul, HSDB 3176, I 2065, ICI 45520, Ikopal, Inderal, Inderal LA, Inderalici, Inderex, Indermigran, Indobloc, Innopran, InnoPran XL, KEMI, Kidoral, Naprilin, Nedis, Nelderal, Noloten, Novopranol, NSC 91523, NSC-91523, Obsidan, Oposim, Panolol, Prandol, Pranix, Prano-Puren, Proberta LA, Procor, Pronovan, Propabloc, Propadex, Propalong, Propayerst, Prophylux, Propra vt ct, Proprahexal, Propral, Propranolol chloride, Propranolol HCl, Propranolol hydrochloride, Propranolol hydrochloride intensol, Propranovitan, Propranur, Propraratiopharm, Prosin, Pur-Bloka, Pylapron, R+C5989educor, Rapynogen, Sagittol, Sawatol, Scandrug, Sinal, Sloprolol, Sudenol, Tensiflex, Tesnol, Tiperal, Tonum, UNII-F8A3652H1V
SMILES:
c12c(OCC(CNC(C)C)O)cccc1cccc2.Cl
AHFS Code:
24:24.0
InChi:
1S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18H,10-11H2,1-2H3;1H
General Reference:
General Reference:

  1. Brunet A, Orr SP, Tremblay J, Robertson K, Nader K, Pitman RK: Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. J Psychiatr Res. 2007 Jun 21;. Pubmed
  2. Ohnishi ST, Sadanaga KK, Katsuoka M, Weidanz WP: Effects of membrane acting-drugs on plasmodium species and sickle cell erythrocytes. Mol Cell Biochem. 1989 Nov 23-Dec 19;91(1-2):159-65. Pubmed
  3. Singh N, Puri SK: Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis. Acta Trop. 2000 Nov 2;77(2):185-93. Pubmed
  4. Murphy SC, Harrison T, Hamm HE, Lomasney JW, Mohandas N, Haldar K: Erythrocyte G protein as a novel target for malarial chemotherapy. PLoS Med. 2006 Dec;3(12):e528. Pubmed

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

LGM currently offers Monoclonal Antibodies (mAbs) for non-GMP/R&D use. Please inquire about Monoclonal Antibodies produced under GMP conditions.

Questions? Call our customer API support number 1-(800)-881-8210. 

Ask us about this product

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants
  • Technical packages as well as access to filed DMF, ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any submission type based on specific customer requirements

Find an API Product

SEARCH
Generic filters